Advancing Pharmacometrics in Africa: A Continental Shift Towards Model-Informed Drug Development
The 2025 Pharmacometrics Africa Conference (PMXAC-2025) marked a pivotal transition for quantitative pharmacology on the continent, moving from foundational capacity-building to scientific leadership and regulatory influence. This hybrid event in Kampala, Uganda, convened over 100 delegates from 14 countries to discuss the integration of pharmacometrics—the science of interpreting drug behavior through mathematical models—into African healthcare and drug regulation. Key presentations highlighted the application of advanced modeling techniques like physiologically based pharmacokinetic (PBPK) modeling for safely extrapolating drug exposure in understudied populations such as pregnant women and children, and model-based bioequivalence (MBBE) for resource-limited settings. A strong emphasis was placed on open-source tools to promote technical equity, while discussions outlined eight strategic priorities for sustainable progress, including funding, leadership, and multi-sector partnerships to drive model-informed drug development and personalized medicine across Africa.
Study Significance: For pharmacologists and clinical researchers, this report signals a critical evolution in how drug development and regulatory science can be tailored for diverse, resource-variable settings. The focus on PBPK and model-based approaches provides a methodological framework for optimizing drug dosing and predicting drug-drug interactions in populations often excluded from traditional clinical trials. This shift towards African-led pharmacometric innovation has direct implications for designing more effective and equitable clinical trials, strengthening local regulatory pathways, and ultimately improving therapeutic outcomes through precision dosing.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
